Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency
- PMID: 15878852
- DOI: 10.1074/jbc.C500169200
Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency
Abstract
The removal of extracellular amino acids or leucine alone inhibits the ability of the mammalian target of rapamycin (mTOR) to signal to the raptor-dependent substrates, p70 S6 kinase and 4E-BP. This inhibition can be overcome by overexpression of the Rheb GTPase. Rheb binds directly to the amino-terminal lobe of the mTOR catalytic domain, and activates mTOR kinase in a GTP-dependent manner. Herein we show that the binding of Rheb to endogenous and recombinant mTOR is reversibly inhibited by withdrawal of all extracellular amino acids or just leucine. The effect of amino acid withdrawal is not attributable to changes in Rheb-GTP charging; amino acid withdrawal does not alter the GTP charging of recombinant Rheb. Moreover, the binding of mTOR to Rheb mutants that are unable to bind guanyl nucleotide in vivo is also inhibited by amino withdrawal. The inhibitory effect of amino acid withdrawal is exerted through an action on mTOR, at a site largely distinct from that responsible for the binding of Rheb; deletion of the larger, carboxyl-terminal lobe of the mTOR catalytic domain eliminates the inhibitory effect of amino acid withdrawal on Rheb binding, without altering Rheb binding per se. The lesser ability of the mTOR catalytic domain to bind Rheb after amino acid withdrawal does not persist after extraction and purification of the mTOR polypeptide. Amino acid withdrawal may generate an inhibitor of the Rheb-mTOR interaction that interferes with the signaling function of TOR complex 1.
Similar articles
-
The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.J Biol Chem. 2005 May 13;280(19):18717-27. doi: 10.1074/jbc.M414499200. Epub 2005 Mar 16. J Biol Chem. 2005. PMID: 15772076
-
Rheb binds and regulates the mTOR kinase.Curr Biol. 2005 Apr 26;15(8):702-13. doi: 10.1016/j.cub.2005.02.053. Curr Biol. 2005. PMID: 15854902
-
Amino acid regulation of TOR complex 1.Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E592-602. doi: 10.1152/ajpendo.90645.2008. Epub 2008 Sep 2. Am J Physiol Endocrinol Metab. 2009. PMID: 18765678 Free PMC article. Review.
-
Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.Science. 2007 Nov 9;318(5852):977-80. doi: 10.1126/science.1147379. Science. 2007. PMID: 17991864
-
Molecular mechanisms through which amino acids mediate signaling through the mammalian target of rapamycin.Curr Opin Clin Nutr Metab Care. 2004 Jan;7(1):39-44. doi: 10.1097/00075197-200401000-00008. Curr Opin Clin Nutr Metab Care. 2004. PMID: 15090902 Review.
Cited by
-
Drugs of abuse hijack a mesolimbic pathway that processes homeostatic need.Science. 2024 Apr 19;384(6693):eadk6742. doi: 10.1126/science.adk6742. Epub 2024 Apr 19. Science. 2024. PMID: 38669575
-
African Swine Fever Virus Host-Pathogen Interactions.Subcell Biochem. 2023;106:283-331. doi: 10.1007/978-3-031-40086-5_11. Subcell Biochem. 2023. PMID: 38159232
-
The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics.Int J Mol Sci. 2023 Jun 26;24(13):10651. doi: 10.3390/ijms241310651. Int J Mol Sci. 2023. PMID: 37445831 Free PMC article. Review.
-
The role of TSC2 in breast cancer: a literature review.Front Oncol. 2023 May 12;13:1188371. doi: 10.3389/fonc.2023.1188371. eCollection 2023. Front Oncol. 2023. PMID: 37251941 Free PMC article. Review.
-
New Insights into the Regulation of mTOR Signaling via Ca2+-Binding Proteins.Int J Mol Sci. 2023 Feb 15;24(4):3923. doi: 10.3390/ijms24043923. Int J Mol Sci. 2023. PMID: 36835331 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous